Today we bring you more good news about a CIRM-funded clinical trial for spinal cord injury that’s received a lot of attention lately in the news. Asterias Biotherapeutics has treated its first patient in an expanded patient population of spinal cord injury patients who suffer from cervical, or neck, injuries. In late August, Asterias reported … Continue reading Full Steam Ahead: First Patient is Dosed in Expanded CIRM Spinal Cord Injury Trial
Stem cell stories that caught our eye: two studies of the heart and cool stem cell art
Here are some stem cell stories that caught our eye this past week. Some are groundbreaking science, others are of personal interest to us, and still others are just fun. Understanding Heart Defects. Healthy heart tissue is made up of smooth, solid muscle, which is essential for normal heart function. Patients with a heart defect … Continue reading Stem cell stories that caught our eye: two studies of the heart and cool stem cell art
Funding stem cell research targeting a rare and life-threatening disease in children
If you have never heard of cystinosis you should consider yourself fortunate. It’s a rare condition caused by an inherited genetic mutation. It hits early and it hits hard. Children with cystinosis are usually diagnosed before age 2 and are in end-stage kidney failure by the time they are 9. If that’s not bad enough … Continue reading Funding stem cell research targeting a rare and life-threatening disease in children
Science and Improv: Spotlight on CIRM Bridges Scholar Jill Tsai
As part of our CIRM scholar series, we’re featuring the research and career accomplishments of CIRM funded students. What do science and improv have in common? The answer is not a whole lot. However, I recently met a talented student from our CIRM Bridges master’s program who one day is going to change this. Meet … Continue reading Science and Improv: Spotlight on CIRM Bridges Scholar Jill Tsai
Faulty fat stem cells & obesity-related diabetes
You see it in the news all the time: more and more people around the world are obese and as a result they’re at a higher risk for diabetes, heart disease and cancer. In fact, 90% of individuals with type 2 diabetes are overweight or obese. “Healthy” obese individuals protected from diabetes and other complications … Continue reading Faulty fat stem cells & obesity-related diabetes
CIRM Grantees Reflect on Ten Years of iPS Cells
For the fourth entry for our “Ten Years of Induced Pluripotent Stem (iPS) Cells” series, which we’ve been posting all month, I reached out to three of our CIRM grantees to get their perspectives on the impact of iPSC technology on their research and the regenerative medicine field as a whole: Step back in time … Continue reading CIRM Grantees Reflect on Ten Years of iPS Cells
Stem cell stories that caught our eye: 3D mini-lungs, Parkinson’s culprit, Motherless babies!
Here are some stem cell stories that caught our eye this past week. Some are groundbreaking science, others are of personal interest to us, and still others are just fun. Mimicking human air sacs – a new lab tool for studying respiratory disease Studying a flat lawn of cells in a petri dish is so … Continue reading Stem cell stories that caught our eye: 3D mini-lungs, Parkinson’s culprit, Motherless babies!
Asterias’ stem cell clinical trial shows encouraging results for spinal cord injury patients
When researchers are carrying out a clinical trial they have two goals: first, show that it is safe (the old “do no harm” maxim) and second, show it works. One without the other doesn’t do anyone any good in the long run. A few weeks ago Asterias Biotherapeutics showed that their CIRM-funded stem cell therapy … Continue reading Asterias’ stem cell clinical trial shows encouraging results for spinal cord injury patients
CIRM’s Randy Mills: New FDA rules for stem cells won’t fix the problem
For the last two days the Food and Drug Administration (FDA) has been holding a hearing in Bethesda, Maryland on new regulations that would tighten control over stem cell treatments. The FDA invited public testimony during the hearing on the regulations that would impact many of the clinics that currently offer unproven therapies The testimony … Continue reading CIRM’s Randy Mills: New FDA rules for stem cells won’t fix the problem
Salk scientists explain why brain cells are genetically diverse
I’ve always wondered why some sets of genetically identical twins become not so identical later in life. Sometimes they differ in appearance. Other times, one twin is healthy while the other is plagued with a serious disease. These differences can be explained by exposure to different environmental factors over time, but there could also be … Continue reading Salk scientists explain why brain cells are genetically diverse
The Stem Cellar 